Your browser doesn't support javascript.
loading
Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study.
Singh, Dave; Ciurlia, Giorgia; Piccinno, Annalisa; Muraro, Annamaria; Bocchi, Maria; Scuri, Mario.
Afiliación
  • Singh D; University of Manchester, Medicines Evaluation Unit, The Langley Building, University Hospital of South Manchester, Southmoor Rd, Wythenshawe M23 9QZ, United Kingdom. Electronic address: DSingh@meu.org.uk.
  • Ciurlia G; Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy.
  • Piccinno A; Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy.
  • Muraro A; Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy.
  • Bocchi M; Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy.
  • Scuri M; Chiesi Farmaceutici SpA, Via Palermo 26/A, 43122 Parma, Italy.
Pulm Pharmacol Ther ; 42: 43-51, 2017 02.
Article en En | MEDLINE | ID: mdl-28065679

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Broncodilatadores / Beclometasona / Enfermedad Pulmonar Obstructiva Crónica / Fumarato de Formoterol Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Broncodilatadores / Beclometasona / Enfermedad Pulmonar Obstructiva Crónica / Fumarato de Formoterol Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article